Search results for: COVID-19 Research
Filter search results
Early Experience with Health Technology Assessment of Gene Therapies in the United States: Pricing and Paying for Cures
1 February 2019
Gene therapies, which can provide cures for diseases, are a new area of research for ICER. Some are within two to three years of becoming available publicly. This is exciting,…
Around The World in HTAs: The Netherlands – 5 Routes for New Tech
24 May 2023
…Development (ZonMw) supports research to further develop and make available HTA research designs, analytical techniques, and outcomes measures for existing and new technologies to collect data for decision-making regarding appropriate…
OHE Study on Pharmaceutical R&D Costs Released
3 December 2012
How much it costs to research and develop a successful new medicine has been an important policy issue at least since the 1960s. Cost estimates matter not just because of…
Shalu Jain
29 June 2023
…of Health Research (DHR), MOHFW, New Delhi, India as Scientist-C and played a key role in establishing Health Technology Assessment in India (HTAIn), a unit within the health ministry to…
Join OHE on Twitter, LinkedIn and SlideShare
21 January 2013
…issues. OHE research and analyses presented in outside forums now are available on the OHE News SlideShare site. OHE’s company page on LinkedIn tracks OHE activities, research and publications, providing…
Understanding the Context, Selecting the Standards: A Framework to Guide the Optimal Development and Use of Real-World Evidence for Coverage and Formulary Decisions
1 March 2018
OHE Research Paper 18/02: Real World Evidence (RWE) – This paper provides a framework and specific steps to help both manufacturers and payers meet the challenge of developing observational RWE…
Spotlight on OHE: Understanding Value Based Pricing
12 February 2013
Value based pricing (VBP) is increasingly common in health care systems worldwide. OHE continues to make important contributions to the debate about VBP approaches and application through its research, publications…
The value of cell and gene therapies to the UK economy
20 October 2025
Share this: Download publication Chris Sampson Sukanya Subramaniyan Matthew Napier Hania El Banhawi Grace Hampson Panos Kefalas Laura Beswick Jacqueline Barry Matthew Durdy Key takeaways: Our research estimates that widening…
OHE’s Adrian Towse is ISPOR President-Elect for 2013-14
13 May 2013
…outcomes research (HEOR), thus supporting the next generation of researchers. These challenges are intertwined. Globalisation, which involves understanding the realities of decision making in health systems, particularly in emerging economies,…